Bioactivity | Celivarone (SSR149744C) is a orally active noniodinated benzofuran derivative with antiarrhythmic properties. Celivarone has the potential for atrial fibrillation and in ventricular arrhythmias research[1]. |
Invitro | Celivarone (SSR149744C) 具有 I、II、III 和 IV 类抗心律失常试剂的电生理学和血流动力学特性[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Celivarone 相关抗体: |
In Vivo | 在麻醉犬迷走神经诱发的心房颤动 (AF) 中,Celivarone (SSR149744C)(3 和 10 mg/kg IV)可终止所有 7 只犬的 AF,并防止 7 只犬中的 4 只再次诱发[2] .在心室水平,Celivarone(0.1-10 mg/kg IV 和 3-90 mg/kg PO)可预防麻醉大鼠再灌注引起的心律失常,并具有剂量效应关系,并且剂量为 30-90 mg/kg , 灌胃给药,可降低清醒大鼠永久结扎左冠状动脉后的早期(0-24 小时)死亡率[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
CAS | 401925-43-7 |
Formula | C34H47NO4 |
Molar Mass | 533.74 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Avinash R Khitri, et al. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter. J Cardiovasc Electrophysiol. 2012 May;23(5):462-72. [2]. Patrick Gautier, et al. In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias. J Cardiovasc Pharmacol. 2005 Feb;45(2):125-35. |